Income Statement | | | | | | | | | | | | |
| | | | | | | | | | | | Press Release |
HKD | Fiscal Year Ending | | Latest |
(in millions) | Dec-15 | Dec-16 | Dec-17 | Dec-18 | Dec-19 | Dec-20 | Dec-21 | Dec-22 | Dec-23 | Dec-24 | | Dec-24 |
| FY - 9 | FY - 8 | FY - 7 | FY - 6 | FY - 5 | FY - 4 | FY - 3 | FY - 2 | FY - 1 | FY | | LTM |
| | | | | | | | | | | | |
Revenue | 106 | 634 | 1,451 | 2,148 | 2,676 | 1,463 | 1,728 | 1,568 | 2,150 | 1,688 | | 1,688 |
% Growth | NA | 498.8% | 129.0% | 48.1% | 24.6% | -45.3% | 18.1% | -9.2% | 37.1% | -21.5% | | |
| | | | | | | | | | | | |
Cost of Revenue | (111) | (587) | (1,284) | (1,950) | (2,452) | (1,368) | (1,609) | (1,519) | (2,085) | (1,639) | | (1,639) |
Gross Profit | (5) | 47 | 168 | 198 | 225 | 95 | 119 | 50 | 65 | 50 | | 50 |
% Revenue | -4.6% | 7.4% | 11.5% | 9.2% | 8.4% | 6.5% | 6.9% | 3.2% | 3.0% | 2.9% | | 2.9% |
| | | | | | | | | | | | |
Research and Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Selling and Marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
General and Admin | (85) | (123) | (180) | (285) | (317) | (499) | (244) | (172) | (161) | (148) | | (148) |
Other Inc / (Exp) | 138 | 266 | 109 | 559 | 400 | (3,325) | 2 | 277 | 396 | 323 | | 323 |
Total Operating Exp | 53 | 143 | (71) | 274 | 83 | (3,824) | (243) | 105 | 235 | 175 | | 175 |
| | | | | | | | | | | | |
Operating Income | 48 | 190 | 96 | 472 | 308 | (3,729) | (124) | 155 | 301 | 225 | | 225 |
% Revenue | 45.4% | 30.0% | 6.6% | 22.0% | 11.5% | -254.9% | -7.1% | 9.9% | 14.0% | 13.3% | | 13.3% |
| | | | | | | | | | | | |
Interest Expense | (32) | (90) | (156) | (213) | (211) | (188) | (147) | (133) | (190) | (108) | | (108) |
Pre-tax Income | 16 | 100 | (60) | 259 | 97 | (3,917) | (270) | 22 | 111 | 116 | | 116 |
Earnings of Discontinued Ops. | (14) | (14) | 69 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Provision for Taxes | 5 | (0) | (6) | 2 | (23) | 111 | (8) | (11) | (8) | (31) | | (31) |
Net Income to Company | 7 | 85 | 4 | 262 | 74 | (3,806) | (279) | 12 | 103 | 85 | | 85 |
% Margin | 6.5% | 13.5% | 0.3% | 12.2% | 2.8% | -260.2% | -16.1% | 0.7% | 4.8% | 5.0% | | 5.0% |
| | | | | | | | | | | | |
Minority Interest in Earnings | 10 | 15 | (16) | (1) | (85) | 90 | 3 | 7 | (11) | 0 | | 0 |
Net Income to Stockholders | 17 | 100 | (12) | 261 | (11) | (3,716) | (275) | 19 | 91 | 85 | | 85 |
| | | | | | | | | | | | |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Other Adj. | 14 | 14 | (69) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
| | | | | | | | | | | | |
Net Income to Common | 31 | 114 | (82) | 261 | (11) | (3,716) | (275) | 19 | 91 | 85 | | 85 |
% Margin | 29.7% | 17.9% | -5.6% | 12.1% | -0.4% | -254.0% | -15.9% | 1.2% | 4.2% | 5.0% | | 5.0% |
| | | | | | | | | | | | |
As Reported | | | | | | | | | | | | |
Basic EPS (Continuing Ops) | 0.01 | 0.01 | (0.01) | 0.02 | (0.00) | (0.29) | (0.02) | 0.00 | 0.00 | 0.00 | | 0.00 |
Diluted EPS (Continuing Ops) | 0.01 | 0.01 | (0.01) | 0.02 | (0.00) | (0.29) | (0.02) | 0.00 | 0.00 | 0.00 | | 0.00 |
| | | | | | | | | | | | |
WA Basic Shares Out. | 5,249.34 | 7,779.98 | 9,816.52 | 11,465.47 | 12,986.11 | 12,986.11 | 12,986.11 | 13,039.54 | 22,736.11 | 22,736.11 | | 22,736.11 |
WA Diluted Shares Out. | 5,250.28 | 7,839.19 | 10,312.94 | 11,655.96 | 12,986.11 | 12,986.11 | 12,986.11 | 13,039.54 | 22,736.11 | 22,736.11 | | 22,736.11 |
| | | | | | | | | | | | |
EBITDA, EBIT Reconciliation | | | | | | | | | | | | |
EBT, Incl. Unusual Items | 16 | 100 | (60) | 259 | 97 | (3,917) | (270) | 22 | 111 | 116 | | 116 |
Addback: Net Interest Expense | 32 | 90 | 156 | 213 | 211 | 188 | 147 | 133 | 190 | 108 | | 108 |
Addback: Other Non Operating Expenses, Total | (8) | (19) | (75) | (379) | (421) | (335) | (398) | (305) | (410) | (353) | | (353) |
Addback: Depreciation & Amortization | 40 | 40 | 68 | 136 | 120 | 144 | 63 | 67 | 100 | 100 | | 100 |
Addback: Restructuring Charges | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Merger / Acquisition Expenses | 1 | 3 | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Goodwill Impairment | 0 | 0 | 0 | 0 | 0 | 870 | 28 | 0 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Invest. | 0 | (51) | (36) | 53 | (2) | 560 | 1 | (19) | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Assets | (135) | (209) | (15) | (66) | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Asset Writedown | 0 | 0 | 0 | 21 | 0 | 829 | 18 | 8 | 19 | 5 | | 5 |
Addback: In Process R&D Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Insurance Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Legal Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 80 | (31) | (49) | 0 | | 0 |
Addback: Other Unusual Items | 0 | 0 | 0 | (198) | 0 | 1,431 | 225 | (31) | (10) | 25 | | 25 |
Adjusted EBITDA | (53) | (46) | 43 | 39 | 5 | (231) | (107) | (156) | (49) | 2 | | 2 |
% Margin | -50.2% | -7.2% | 3.0% | 1.8% | 0.2% | -15.8% | -6.2% | -9.9% | -2.3% | 0.1% | | 0.1% |
| | | | | | | | | | | | |
Adjusted EBIT | (93) | (86) | (25) | (97) | (115) | (375) | (170) | (223) | (149) | (98) | | (98) |
% Margin | -88.2% | -13.5% | -1.7% | -4.5% | -4.3% | -25.6% | -9.9% | -14.2% | -6.9% | -5.8% | | -5.8% |
| | | | | | | | | | | | |
Adjusted Net Income Reconciliation | | | | | | | | | | | | |
Net Income to Company | 7 | 85 | 4 | 262 | 74 | (3,806) | (279) | 12 | 103 | 85 | | 85 |
Addback: Unusual Items | (134) | (256) | (46) | (190) | (2) | 3,690 | 351 | (73) | (40) | 30 | | 30 |
Less: Tax Benefit of Unusual Items (26%) | 35 | 67 | 12 | 49 | 0 | (959) | (91) | 19 | 10 | (8) | | (8) |
Adjusted Net Income | (92) | (104) | (30) | 121 | 72 | (1,076) | (19) | (42) | 73 | 107 | | 107 |
% Margin | -87.1% | -16.5% | -2.1% | 5.6% | 2.7% | -73.5% | -1.1% | -2.7% | 3.4% | 6.4% | | 6.4% |